TREK Diagnostic Systems, Inc.
TREK Diagnostic Systems, Inc. (TREK) is a privately-held medical device company, engaged in the manufacture and distribution of automated systems for diagnostic laboratories. The company is a subsidiary of Magellan Biosciences, Inc. The company develops products such as electronic pipettes, antimicrobial strips, MIC plates, organism test sets, autoreaders and urine culture devices used in clinical, pharmaceutical and veterinary diagnostic laboratories. TREK develops fully customizable systems with an option of automated, semi-automated, or manual equipment to cover all diagnostic testing needs in the clinical laboratory, veterinary and pharmaceutical sectors under the brand name Sensititre. TREK is ISO 9001:2000 and ISO 13485:2003 certified. Its products are marketed through a broad range of distributors across Canada and the US. It is headquartered in Ohio, the US.
TREK introduced Sensititre Gram positive MIC plates that were approved by the FDA for D-Test and Cefoxitin screening.